Key result
Glutathione infusion before and after primary PCI reduced neutrophil to lymphocyte ratio, hsCRP, NOX2 activation, TNF-α, and cTpT release compared with placebo.
Why the study?
It was hypothesized that glutathione administration immediately before and after primary PCI could modulate immune cell activation and prevent infarct expansion.
Does glutathione infusion reduce inflammatory response and improve left ventricular function in patients with STEMI undergoing primary PCI?
RCT (n=100)
Randomly assigned
Does glutathione infusion reduce inflammatory response and improve left ventricular function in patients with STEMI undergoing primary PCI?
Glutathione infusion before and after primary PCI in STEMI patients blunts the inflammatory response and may prevent adverse left ventricular remodeling.
Answers are grounded in this paper and cite their sources.
Supports adjunctive glutathione in STEMI PCI to limit injury; extends mechanistic data with randomized evidence on surrogates.
Background Glutathione is a water‐soluble tripeptide with a potent oxidant scavenging activity. We hypothesized that glutathione administration immediately before and after primary angioplasty (primary percutaneous coronary intervention) could be effective in modulating immune cell activation, thereby preventing infarct expansion. Methods and Results One hundred consecutive patients with ST‐segment–elevation myocardial infarction, scheduled to undergo primary percutaneous coronary intervention were randomly assigned before the intervention to receive an infusion of glutathione (2500 mg/25 mL over 10 minutes), followed by drug administration at the same doses at 24, 48, and 72 hours elapsing time or placebo. Total leukocytes, NOX2 (nicotinamide adenine dinucleotide phosphate oxidase 2) activation, NO bioavailability, cTpT (serum cardiac troponin T), hsCRP (high‐sensitivity C‐reactive protein), and TNF‐α (tumor necrosis factor α) levels were measured. Left ventricular size and function were assessed within 120 minutes, 5 days, and 6 months from percutaneous coronary intervention. Following reperfusion, a significant reduction of neutrophil to lymphocyte ratio ( P <0.0001), hsCRP generation ( P <0.0001), NOX2 activation ( P <0.0001), TNF‐α levels ( P <0.001), and cTpT release ( P <0.0001) were found in the glutathione group compared with placebo. In treated patients, blunted inflammatory response was linked to better left ventricular size and function at follow‐up ( r =0.78, P <0.005). Conclusions Early and prolonged glutathione infusion seems able to protect vital myocardial components and endothelial cell function against harmful pro‐oxidant and inflammatory environments, thus preventing maladaptive cardiac repair and left ventricular adverse remodeling. Registration URL: https://www.clinicaltrialsregister.eu ; Unique identifier: 2014‐004486‐25.
No takes yet. Share an insight, caveat, or question.
Tanzilli et al. (2021) conducted an RCT in ST-segment-elevation myocardial infarction (n=100). Glutathione vs. Placebo was evaluated on Neutrophil to lymphocyte ratio, hsCRP generation, NOX2 activation, TNF-α levels, and cTpT release (p=<0.0001). Glutathione infusion before and after primary PCI reduced neutrophil to lymphocyte ratio, hsCRP, NOX2 activation, TNF-α, and cTpT release compared with placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: